Taysha Gene Therapies Inc...
(TSHA)
undefined
undefined%
At close: undefined
2.02
-1.70%
After-hours Dec 13, 2024, 07:58 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -111.57M | -166.01M | -174.52M | -60.01M | -4.46M |
| Depreciation & Amortization | 1.37M | 1.17M | 492.00K | 9.00K | - |
| Stock-Based Compensation | 7.91M | 18.04M | 18.18M | 3.35M | - |
| Other Working Capital | -15.72M | 26.32M | 14.17M | -2.07M | 540.00K |
| Other Non-Cash Items | 47.28M | 39.89M | 10.14M | 26.03M | 3.92M |
| Deferred Income Tax | - | - | - | - | - |
| Change in Working Capital | -18.01M | 18.52M | 28.67M | -111.00K | 540.00K |
| Operating Cash Flow | -73.02M | -88.39M | -117.04M | -30.73M | 135.00K |
| Capital Expenditures | -7.37M | -24.87M | -21.55M | -9.08M | - |
| Acquisitions | - | - | - | - | - |
| Purchase of Investments | - | - | - | - | - |
| Sales Maturities Of Investments | - | - | - | - | - |
| Other Investing Acitivies | -3.48M | -61.00K | -6.25M | -9.00M | - |
| Investing Cash Flow | -7.35M | -24.93M | -21.55M | -9.08M | - |
| Debt Repayment | -3.45M | - | 39.96M | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - |
| Other Financial Acitivies | -947.00K | -1.15M | -874.00K | 125.21M | - |
| Financial Cash Flow | 136.39M | 52.10M | 39.08M | 291.06M | - |
| Net Cash Flow | 56.02M | -61.22M | -99.51M | 251.25M | 135.00K |
| Free Cash Flow | -80.39M | -113.26M | -138.60M | -39.81M | 135.00K |